'Oral Medication Dispensers in Clinical Research,' a Technical Paper from Baxa Corporation, is Now Posted At PublicRelationsNewsroom.com

Share Article

"Oral Medication Dispensers in Clinical Research," a Technical Paper from Baxa Corporation is now posted for media and professional access on PublicRelationsNewsroom.com. Oral dispensers (syringes), long recognized as the safest and most accurate method to administer oral liquid medications, are especially valuable in clinical research where dosage accuracy has fundamental importance.

Baxa Corporation's "Oral Medication Dispensers in Clinical Research," is now posted for media and professional access on PublicRelationsNewsroom.com. Oral dispensers (syringes), long recognized as the safest and most accurate method to administer oral liquid medications, are especially valuable in clinical research where dosage accuracy has fundamental importance. This paper, written by Michael Hurst, RPh, MBA, Vice President - Infusion Systems for Baxa Corporation, is found at http://publicrelationsnewsroom.com/_wsn/page2.html.

Oral dispensers were the first Baxa product and the Exacta-Med® brand has been the market leader for more than 30 years. Exacta-Med Dispensers were the first device specially designed for oral liquid delivery only. Baxa also provides specialty dispensers for safe topical and vaginal medication delivery, and its Kwik-Vial™ Containers and accessories provide stability for liquid unit dose drug storage and delivery.

Baxa, a long-time proponent of hospital pharmacy safety initiatives recently launched its state-of-the-art STAR (Skills Training, Academics and Resources) Center for pharmacy and cleanroom skills training. Baxa designed and built the STAR Center as a fully USP 797-compliant pharmacy cleanroom to provide professional education on pharmacy practice, cleanroom principles and compliance to regulatory requirements.

The STAR Center, the only dedicated facility of its kind in the world for hands-on cleanroom experience and training in environmental monitoring and aseptic technique, provides a unique opportunity for industry professionals to learn best practice from subject-matter expert trainers. More information is available at http://www.baxa.com/starcenter.

About Michael Hurst

A national expert on syringe pump intermittent IV infusion technology, Hurst successfully managed the Swedish Medical Center pharmacy in Seattle and has ten years experience as a pharmaceutical industry consultant. He developed dilution, compounding, drug solution expiration tables and IV pharmacy operational recommendations that set the standard for the most common intermittent syringe infusers. At Baxa, he developed the Rapid Rate Infuser - the standard for Adenoscan infusion for cardiac stress monitoring. Currently, he supports business development and pharmacy process improvement activities. Hurst holds a BS in Pharmacy from the University of Washington and an MBA from City University (Bellevue).

About Baxa Corporation

Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for fluid handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of fluid medications. Key products include Rapid-Fill™ Automated Syringe Fillers, Exacta-Med® Oral Dispensers, MicroFuse® Syringe Infusers, Repeater™ Pharmacy Pumps, and Exacta-Mix™ and MicroMacro™ Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Denmark, Finland, France, Germany, Luxembourg and The Netherlands; and distribution partners worldwide. Further information is available at http://www.baxa.com.

Contacts:

Marian Robinson, Vice President, Marketing

Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157

http://www.baxa.com

Maggie Chamberlin Holben, APR, Absolutely Public Relations

303.984.9801, 303.669.3558

http://www.absolutelypr.com

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Maggie Holben
Visit website